Hadad Rafi, Alcalay Roy N, Senderova Inna, Nassar Maria, Milicic Andjelika, Peretz Judith Aharon, Allen Isabel Elaine, Ben-Hayun Rachel, Chasnyk Natalia, Morani Ilham, Elkoshi Nadav, Valcour Victor, Schlesinger Ilana
Department of Neurology, Stroke and Cognition Institute, Haifa, Israel.
Department of Neurology, Movements Disorders Institute, Haifa, Israel.
J Parkinsons Dis. 2025 Aug;15(5):1029-1034. doi: 10.1177/1877718X251354986. Epub 2025 Jul 4.
Mutations in the leucine-rich repeat kinase 2 () gene associate with familial and sporadic Parkinson's disease (PD). While various allelic variants have been studied, characteristics of R1441C carriers remain underexplored. We compared PD patients carrying the R1441C mutation (90% Israeli Arabs) to those carrying the G2019S (70% Ashkenazi Jews) and R1441G (42% Basque) variants. R1441C carriers exhibited a distinct clinical phenotype characterized by severe motor and non-motor symptoms and worse scores on the Montreal Cognitive Assessment. These findings highlight the importance of ethnic diversity and genetic stratification in PD research. These results need confirmation in larger, more diverse samples.
富含亮氨酸重复激酶2()基因突变与家族性和散发性帕金森病(PD)相关。虽然已经对各种等位基因变体进行了研究,但R1441C携带者的特征仍未得到充分探索。我们将携带R1441C突变的PD患者(90%为以色列阿拉伯人)与携带G2019S(70%为阿什肯纳兹犹太人)和R1441G(42%为巴斯克人)变体的患者进行了比较。R1441C携带者表现出独特的临床表型,其特征为严重的运动和非运动症状以及在蒙特利尔认知评估中得分更低。这些发现凸显了种族多样性和基因分层在PD研究中的重要性。这些结果需要在更大、更多样化的样本中得到证实。